Rising Incidence of Contact Dermatitis in Cosmetic and Personal Care Products
As industries develop more chemical extraction techniques for botanical ingredients, the incidence of contact dermatitis is rising. Contact dermatitis, either irritant or allergic, is the most common occupational skin disease. The lifetime incidence currently exceeds 50%. Allergic contact dermatitis occurs due to type IV hypersensitivity. This delayed-type hypersensitivity leads to a T-cell–mediated immune response, which develops around 72 hours after exposure to the allergen.
Diagnosis and Treatment of Allergic Contact Dermatitis
Doctors typically diagnose allergic contact dermatitis clinically. They identify potential allergens or use patch testing. Treatment usually involves topical steroids or anti-inflammatories to manage the rash. Once the allergen is identified, patients should avoid it to prevent future reactions.
The Mechanism of Delayed-Type Hypersensitivity
In delayed-type hypersensitivity, T-cell receptors recognize a peptide antigen bound to major histocompatibility complex (MHC) proteins. This recognition triggers an inflammatory immune response. However, in a recent study, researchers found that many known contact allergens do not fit the typical chemical structure of TCR-peptide-MHC complexes. These allergens include small molecules, cations, or metals, and they are commonly found in drugs, oils, cosmetics, skin creams, or fragrances. Therefore, the mechanism behind how these nonpeptidic molecules cause T-cell–mediated hypersensitivity remains unclear.
Exploring the Role of CD1a in Allergic Reactions
Investigators from Brigham and Women’s Hospital, Columbia University, and Monash University studied the role of CD1a, a protein found in immune cells, in allergic reactions. Dr. D. Branch Moody, the co-senior author, and his team questioned the traditional view that T-cell–mediated allergic reactions only happen when T cells respond to proteins or peptides. They found that fragrance can also trigger this reaction through a protein called CD1a.
How CD1a Triggers Allergic Contact Dermatitis
In their study, the team identified CD1a as the primary protein responsible for eliciting allergic contact dermatitis in response to nonpeptidic allergens. They found that balsam of Peru, benzyl benzoate, benzyl cinnamate, and farnesol—all commonly found in cosmetics and personal care products—triggered this reaction after positive patch tests. Their findings suggest that these hydrophobic contact allergens form complexes with CD1a. These complexes displace self-lipids normally bound to CD1a, exposing regions that stimulate T-cells, causing hypersensitivity.
The Implications of These Findings
The researchers believe that understanding how these ingredients trigger an immune response on a molecular level could lead to better treatments for allergic skin diseases. Identifying other molecules that could block this response may offer potential treatments to mitigate allergic reactions from these common ingredients.
Shop our favorite skincare and more on Derm to Door.com!
Head back to our blog here!
